Showing results (401-410 of 499) with videos related to
Sort By:
Pageof 50
Frontiers in Cellular and Infection Microbiology|April 4, 2022
Neutralization Sensitivity of HIV-1 CRF07_BC From an Untreated Patient With a Focus on Evolution Over TimeLijie Wang, Shujia Liang, Jianhua Huang, et al.Antimicrobial Agents and Chemotherapy|June 10, 2015
ADS-J1 inhibits semen-derived amyloid fibril formation and blocks fibril-mediated enhancement of HIV-1 infectionTianrong Xun, Wenjuan Li, Jinquan Chen, et al.Viruses|September 22, 2019
A Novel CXCR4 Targeting Protein SDF-1/54 as an HIV-1 Entry InhibitorSuiyi Tan, Wenjuan Li, Zhaofeng Li, et al.Chemical Science|June 15, 2018
An effective strategy for recapitulating N-terminal heptad repeat trimers in enveloped virus surface glycoproteins for therapeutic applicationsWenqing Lai, Chao Wang, Fei Yu, et al.Journal of Medical Virology|March 8, 2023
SARS-CoV-2 Omicron XBB subvariants exhibit enhanced fusogenicity and substantial immune evasion in elderly population, but high sensitivity to pan-coronavirus fusion inhibitorsShuai Xia, Fanke Jiao, Lijue Wang, et al.Viruses|March 26, 2022
A Palmitic Acid-Conjugated, Peptide-Based pan-CoV Fusion Inhibitor Potently Inhibits Infection of SARS-CoV-2 Omicron and Other Variants of ConcernQiaoshuai Lan, Jasper Fuk-Woo Chan, Wei Xu, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 8, 2008
Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infectionLanying Du, Guangyu Zhao, Yongping Lin, et al.Journal of Medicinal Chemistry|April 13, 2016
Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitor Agents: Optimization of Diarylanilines with High Potency against Wild-Type and Rilpivirine-Resistant E138K Mutant VirusNa Liu, Lei Wei, Li Huang, et al.Journal of Medicinal Chemistry|December 5, 2008
Development and preclinical studies of broad-spectrum anti-HIV agent (3'R,4'R)-3-cyanomethyl-4-methyl-3',4'-di-O-(S)-camphanoyl-(+)-cis-khellactone (3-cyanomethyl-4-methyl-DCK)Lan Xie, Huan-Fang Guo, Hong Lu, et al.Proceedings of the National Academy of Sciences of the United States of America|October 7, 2020
Decoy nanoparticles protect against COVID-19 by concurrently adsorbing viruses and inflammatory cytokinesLang Rao, Shuai Xia, Wei Xu, et al.Pageof 50